贝卡林对与肠-大脑轴功能障碍相关的疾病的治疗作用
Qichao Hu1, Shuyu Hou1, Baoyi Xiong2,3
1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Molecules (Basel, Switzerland)
|September 28, 2023
概括
拜卡林是一种天然化合物,通过减少神经炎症,抑制肥胖和改善肠道健康来治疗肠-大脑轴障碍有希望. 需要进一步的研究来确认其治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 肠-大脑轴与各种疾病有关,包括神经,代谢和肠道疾病.
- 肠-大脑轴的功能障碍与阿尔茨海默病,帕金森病,抑郁症,肥胖症和炎症性肠病等疾病有关.
- 贝卡林是来自*Scutellaria baicalensis*的一种黄类物质,表现出多种药理学活性.
研究的目的:
- 审查baicalin在肠-大脑轴障碍中的分子机制和治疗点.
- 总结贝卡林对中枢神经系统,新陈代谢和肠道状况的影响.
- 突出贝卡林作为治疗肠-大脑轴相关疾病的潜力.
主要方法:
- 这是一篇叙事性综述,综合了现有关于贝卡林和肠-大脑轴的研究.
- 关于分子机制,药理作用和baicalin的临床相关性的文献搜索.
- 对贝卡林对神经炎症,神经细胞亡,氧化应激和肠道微生物群的影响的分析.
主要成果:
- 拜卡林通过减少中枢神经系统中神经炎症和亡来表现出神经保护作用.
- 它通过抗炎和抗氧化作用抑制肥胖.
- 拜卡林通过调节肠道微生物和短链脂肪酸生产来缓解肠道疾病.
- 这些效应通过肠-大脑轴介导.
结论:
- 巴伊卡林对一系列肠-大脑轴障碍具有显著的治疗潜力.
- 它的生物活性与它调节肠-大脑轴的能力有关.
- 需要进一步的基础研究来验证这些发现并探索临床应用.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
90
07:49Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
3.2K
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
The Blood-brain Barrier
47.5K
Overview
47.5K
Irritable Bowel Syndrome I: Introduction
304
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
Drugs for Treatment of Constipation-Predominant IBS
197
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197
